Drug
Clofarabine
Clofarabine: highest development phase Phase 1/2, developed by Sanofi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Clofarabine NCT00529360 | Phase 1/2 | Acute Lymphoblastic Leukemia |
| Clofarabine NCT01169012 | Phase 1 | Myelodysplastic Syndrome |
Latest
No recent events.
Follow Clofarabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.